2016
DOI: 10.1016/j.bej.2015.11.001
|View full text |Cite
|
Sign up to set email alerts
|

In-vitro release study of hydrophobic drug using electrospun cross-linked gelatin nanofibers

Abstract: a b s t r a c tDelivering hydrophobic drug within hydrophilic polymer matrix as carrier is usually a challenge. Here we report the synthesis of gelatin nanofibers by electrospinning, followed by testing them as a potential carrier for oral drug delivery system for a model hydrophobic drug, piperine. Electrospun gelatin nanofibers were crosslinked by exposing to saturated glutaraldehyde (GTA) vapor, to improve their water resistive properties. An exposure of only 6 min was not only adequate to control the early… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
48
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 80 publications
(50 citation statements)
references
References 34 publications
2
48
0
Order By: Relevance
“…A C C E P T E D M A N U S C R I P T 3 within a short time span [19]. We were able to crosslink the mesh by only a few minutes of GTA exposure (6 min) instead of a few hours or even days as reported in literature [20][21][22].…”
Section: Accepted Manuscriptmentioning
confidence: 51%
See 4 more Smart Citations
“…A C C E P T E D M A N U S C R I P T 3 within a short time span [19]. We were able to crosslink the mesh by only a few minutes of GTA exposure (6 min) instead of a few hours or even days as reported in literature [20][21][22].…”
Section: Accepted Manuscriptmentioning
confidence: 51%
“…The probable reason for this kind of common release pattern could be the penetration of water molecules in the mesh which caused swelling of the matrix. Due to swelling, the drug molecules from the outer layers started releasing rapidly, which caused sudden release (65 %) of drug molecules from 6 min crosslinked mesh (G-P NF C6) within 4 h in pH 7.4 [19]. This kind of profile can be used for specific treatment purpose where initial release of drug is required.…”
Section: Accepted Manuscriptmentioning
confidence: 99%
See 3 more Smart Citations